更多开发者作品
The Lancet Neurology
| 1. | [In Context] Creative neurorehabilitation: the art of intervention | Jules Morgan | |
更新于 11 分钟前
近期历史最近 100 条记录
| 2024-11-21 | [In Context] Creative neurorehabilitation: the art of intervention | Jules Morgan | |
| 2024-10-22 | [Personal View] Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic | Shen-Yang Lim, Ai Huey Tan, Azlina Ahmad-Annuar, Njideka Ulunma Okubadejo, Katja Lohmann, Huw R Morris, Tzi Shin Toh, Yi Wen Tay, Lara M Lange, Sara Bandres-Ciga, Ignacio Mata, Jia Nee Foo, Esther Sammler, Joshua Chin Ern Ooi, Alastair J Noyce, Natascha B | |
| 2024-10-22 | [Comment] The global dimension of Parkinson's disease genetics | Thomas Gasser | |
| 2024-10-14 | [Correspondence] The European expertise network for open microvascular surgery | Victor Volovici, Marco Cenzato, Torstein R Meling, EXPERVASC | |
| 2024-09-20 | [Articles] Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial | Suvankar Pal, Jeremy Chataway, Robert Swingler, Malcolm R Macleod, Neil O Carragher, Giles Hardingham, Bhuvaneish Thangaraj Selvaraj, Colin Smith, Charis Wong, Judith Newton, Dawn Lyle, Amy Stenson, Rachel S Dakin, Amarachi Ihenacho, Shuna Colville, Arpan | |
| 2024-09-20 | [Articles] Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials | Xavier Montalban, Patrick Vermersch, Douglas L Arnold, Amit Bar-Or, Bruce A C Cree, Anne H Cross, Eva Kubala Havrdova, Ludwig Kappos, Olaf Stuve, Heinz Wiendl, Jerry S Wolinsky, Frank Dahlke, Claire Le Bolay, Li Shen Loo, Sathej Gopalakrishnan, Yann Hyver | |
| 2024-09-20 | [Comment] Trial designs for motor neuron disease in the 21st century | Steve Vucic | |
| 2024-09-20 | [Comment] Evobrutinib in multiple sclerosis: challenges and unmet goals | Anneke van der Walt | |
| 2024-09-19 | [Correspondence] Equitable access to levetiracetam for people with epilepsy | Arjune Sen, Neerja Chowdhary, Asma Hallab, Michele Romoli, J Helen Cross, Bernadette Cappello | |
| 2024-09-12 | [Personal View] Frailty for neurologists: perspectives on how frailty influences care planning | Marco Canevelli, Caitlin Jackson-Tarlton, Kenneth Rockwood | |
| 2024-09-12 | [Comment] Looking beyond the neurological diagnosis: considering frailty | A Jon Stoessl | |
| 2024-09-11 | [In Context] Learning to be an adult with a disability | Jules Morgan | |
| 2024-08-23 | [Correspondence] The Yaoundé Declaration | Alfred K Njamnshi, Agustin Ibanez, Gagandeep Singh, Mika Pyykko, Vladimir Hachinski, Harris A Eyre, Scientific Technical Committee | |
| 2024-07-27 | [Comment] Amyloid β, γ-secretase, and familial Alzheimer's disease | Marie-Claude Potier, Harald Steiner, Lucía Chávez-Gutiérrez | |
| 2024-07-27 | [Articles] γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS) | Stephanie A Schultz, Lei Liu, Aaron P Schultz, Colleen D Fitzpatrick, Raina Levin, Jean-Pierre Bellier, Zahra Shirzadi, Nelly Joseph-Mathurin, Charles D Chen, Tammie L S Benzinger, Gregory S Day, Martin R Farlow, Brian A Gordon, Jason J Hassenstab, Cliffo | |
| 2024-07-27 | [Articles] Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial | Götz Thomalla, Jens Fiehler, Fabien Subtil, Susanne Bonekamp, Anne Hege Aamodt, Blanca Fuentes, Elke R Gizewski, Michael D Hill, Antonin Krajina, Laurent Pierot, Claus Z Simonsen, Kamil Zeleňák, Rolf A Blauenfeldt, Bastian Cheng, Angélique Denis, Hannes D | |
| 2024-07-27 | [Comment] Endovascular thrombectomy for large ischaemic stroke: outcomes beyond 90 days | Takeshi Morimoto, Fumihiro Sakakibara | |
| 2024-07-24 | [Articles] Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study | Leonard H van den Berg, Jeffrey D Rothstein, Pamela J Shaw, Suma Babu, Michael Benatar, Robert C Bucelli, Angela Genge, Jonathan D Glass, Orla Hardiman, Vincenzo Libri, Theodore Mobach, Björn Oskarsson, Gary L Pattee, John Ravits, Christopher E Shaw, Mark | |
| 2024-07-24 | [Comment] Targeting C9orf72 in people with ALS | Susanne Petri | |
| 2024-07-23 | [In Context] On how a brain beholds beauty | Rui Araújo | |
| 2024-07-19 | [Correspondence] World Brain Day 2024: a focus on brain health and prevention | Wolfgang Grisold, David W Dodick, Alla Guekht, Steven L Lewis, Tissa Wijeratne | |
| 2024-06-28 | [Articles] Prognostic value of tissue bridges in cervical spinal cord injury: a longitudinal, multicentre, retrospective cohort study | Dario Pfyffer, Andrew C Smith, Kenneth A Weber, Andreas Grillhoesl, Orpheus Mach, Christina Draganich, Jeffrey C Berliner, Candace Tefertiller, Iris Leister, Doris Maier, Jan M Schwab, Alan Thompson, Armin Curt, Patrick Freund | |
| 2024-06-28 | [Review] Effects of spaceflight on the brain | Rachael D Seidler, Xiao Wen Mao, Grant D Tays, Tianyi Wang, Peter zu Eulenburg | |
| 2024-06-28 | [Comment] Tissue bridge widths and outcome after spinal cord injury | James Guest | |
| 2024-06-26 | [Review] Sleep and sleep disorders in people with Parkinson's disease | Alex Iranzo, Valerie Cochen De Cock, María Livia Fantini, Laura Pérez-Carbonell, Lynn Marie Trotti | |
| 2024-06-22 | [Articles] Bailout intracranial angioplasty or stenting following thrombectomy for acute large vessel occlusion in China (ANGEL-REBOOT): a multicentre, open-label, blinded-endpoint, randomised controlled trial | Feng Gao, Xu Tong, Baixue Jia, Ming Wei, Yuesong Pan, Ming Yang, Dapeng Sun, Thanh N Nguyen, Zeguang Ren, Francis Demiraj, Xiaoxi Yao, Chenghua Xu, Guangxiong Yuan, Yue Wan, Jianjun Tang, Jing Wang, Yuanfei Jiang, Chaobin Wang, Xiang Luo, Haihua Yang, Rui | |
| 2024-06-22 | [Comment] Bailout angioplasty or stenting for large vessel occlusion | Joanna M Roy, Stavropoula Tjoumakaris | |
| 2024-06-21 | [Articles] Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands | Ilse Huijberts, Florentina M E Pinckaers, Susanne G H Olthuis, Sander M J van Kuijk, Alida A Postma, Hieronymus D Boogaarts, Yvo B W E M Roos, Charles B L M Majoie, Aad van der Lugt, Diederik W J Dippel, Wim H van Zwam, Robert J van Oostenbrugge, MR CLEAN | |
| 2024-06-21 | [Comment] Durable benefit of thrombectomy 6–24 h after stroke onset | Bruce C V Campbell | |
| 2024-06-14 | [Articles] Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial | Mark W Parsons, Vignan Yogendrakumar, Leonid Churilov, Carlos Garcia-Esperon, Bruce C V Campbell, Michelle L Russell, Gagan Sharma, Chushuang Chen, Longting Lin, Beng Lim Chew, Felix C Ng, Akshay Deepak, Philip M C Choi, Timothy J Kleinig, Dennis J Cordat | |
| 2024-06-14 | [Comment] Tenecteplase versus alteplase in stroke thrombolysis: the last piece of the puzzle? | Kazunori Toyoda | |
| 2024-06-13 | [Articles] Optimal drainage time after evacuation of chronic subdural haematoma (DRAIN TIME 2): a multicentre, randomised, multiarm and multistage non-inferiority trial in Denmark | Mads Hjortdal Grønhøj, Thorbjørn Søren Rønn Jensen, Rares Miscov, Ann Kathrine Sindby, Birgit Debrabant, Torben Hundsholt, Carsten Reidies Bjarkam, Bo Bergholt, Kåre Fugleholm, Frantz Rom Poulsen, DACSUHS group | |
| 2024-06-13 | [Comment] Management of subdural haematoma: optimising drainage | Amjad Elmashala, Jonathan Rosand | |
| 2024-06-07 | [In Context] Caring for the carers: the power of personal stories | Udani Samarasekera | |
| 2024-05-21 | [Articles] Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial | Michael Benatar, Thomas Hansen, Dror Rom, Marie A Geist, Thomas Blaettler, William Camu, Magdalena Kuzma-Kozakiewicz, Leonard H van den Berg, Raul Juntas Morales, Adriano Chio, Peter M Andersen, Pierre-Francois Pradat, Dale Lange, Philip Van Damme, Gabrie | |
| 2024-05-21 | [Comment] Amyotrophic lateral sclerosis: a lesson in translation | Orla Hardiman | |
| 2024-05-17 | [Articles] Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trial | Glenn Nielsen, Jon Stone, Teresa C Lee, Laura H Goldstein, Louise Marston, Rachael Maree Hunter, Alan Carson, Kate Holt, Jon Marsden, Marie Le Novere, Irwin Nazareth, Hayley Noble, Markus Reuber, Ann-Marie Strudwick, Beatriz Santana Suarez, Mark J Edwards | |
| 2024-05-17 | [Comment] Progress in physical therapy for functional motor disorder | Mark Hallett | |
| 2024-05-16 | [Articles] Safety and efficacy of active blood-pressure reduction to the recommended thresholds for intravenous thrombolysis in patients with acute ischaemic stroke in the Netherlands (TRUTH): a prospective, observational, cluster-based, parallel-group st | Thomas P Zonneveld, Sarah E Vermeer, Erik W van Zwet, Adrien E D Groot, Ale Algra, Leo A M Aerden, Kees C L Alblas, Frank de Beer, Paul J A M Brouwers, Koen de Gans, H Maarten A van Gemert, Bart C A M van Ginneken, Gerke S Grooters, Patricia H A Halkes, T | |
| 2024-05-16 | [Comment] Challenging the management of blood pressure before intravenous thrombolysis in acute ischaemic stroke | Verónica V Olavarría | |
| 2024-04-20 | [Articles] Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial | Nawaf Yassi, Henry Zhao, Leonid Churilov, Teddy Y Wu, Henry Ma, Huy-Thang Nguyen, Andrew Cheung, Atte Meretoja, Duy Ton Mai, Timothy Kleinig, Jiann-Shing Jeng, Philip M C Choi, Phuc Dang Duc, Helen Brown, Annemarei Ranta, Neil Spratt, Geoffrey C Cloud, Ha | |
| 2024-04-19 | [Corrections] Correction to Lancet Neurol 2024; 23: 393–403 | | |
| 2024-04-18 | [Articles] Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial | CARE pilot trial collaboration | |
| 2024-04-11 | [Articles] RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses | Emil K Gustavsson, Jordan Follett, Joanne Trinh, Sandeep K Barodia, Raquel Real, Zhiyong Liu, Melissa Grant-Peters, Jesse D Fox, Silke Appel-Cresswell, A Jon Stoessl, Alex Rajput, Ali H Rajput, Roland Auer, Russel Tilney, Marc Sturm, Tobias B Haack, Suzan | |
| 2024-04-11 | [Comment] New gene involved in the pathogenesis of Parkinson's disease | Mathias Toft | |
匿名用户只展示最新 100 条榜单历史，更多历史数据请登录后查看，支持时光机按天筛选
Sponsors
